Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

Emil Kraepelin formulated the initial nosology of Alzheimer's disease in the first decade of the 20th century. Nowadays, clinical and pathological presentations (including those associated with ...

Researchers in Scotland are developing a digital tool powered by artificial intelligence that can gauge your risk of ...

Artificial intelligence (AI) 's recent innovation has had several advantages and disadvantages. On the positive side of this ...

Finally, she notes, “Very often, people with hearing loss tend to withdraw from social situations where they find it ...

STOCKHOLM, SE / ACCESSWIRE / January 21, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases af ...

A new study has found older-looking brains in adults with sickle cell disease, helping to explain the cognitive challenges experienced by such individuals. A brain image from a healthy individual ...